Genetic Variants in the p14ARF/MDM2/TP53 Pathway Are Associated with the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated with Radical Resection.
The p14ARF/MDM2/ TP53 pathway is known to play an important role in tumor progression by cell cycle control, although the association between this pathway and the prognosis of esophageal squamous cell carcinoma (ESCC) is unclear. In this study, we explored the association between genetic variants in...
Main Authors: | Jing Li, Yang Tang, Liu Huang, Qianqian Yu, Guangyuan Hu, Xianglin Yuan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4944974?pdf=render |
Similar Items
-
Inactivation of the p53/MDM2/p14ARF pathway in neuroblastoma
by: Carr-Wilkinson, Jane
Published: (2009) -
MYCN and the p53-MDM2/MDMX-p14ARF network in neuroblastoma amd response to MDM2-p53 antagonists
by: Gamble, Laura Dawn
Published: (2012) -
Pinning Control for the p53-Mdm2 Network Dynamics Regulated by p14ARF
by: Oscar J. Suarez, et al.
Published: (2020-08-01) -
Molecular pathology of the p53-MDM2-p14 ARF pathway in soft tissue sarcomas
by: Todd, Ann Radha
Published: (2005) -
TP53 and MDM2 alterations in human bladder cancer
by: Abdel-Fattah, Rana
Published: (1997)